Botanical species · safety record

Clerodendrum phlomidis

The EFSA Compendium of Botanicals holds 4 constituent measurements and 1 adverse-effect record for Clerodendrum phlomidis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Clerodendrum phlomidis L.f.

4Constituent measurements
1Safety records
3Cited sources
11Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 11 licensed products naming Clerodendrum phlomidis as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Root
  • Root extract
  • Stem bark
  • Stem bark extract

What the records describe

Constituents measured

  • Alkaloids1
  • Andrographolide1
  • Cardiac glycosides1
  • Saponins1

Plant parts

  • Leaves3
  • Roots and other underground parts2

Preparations

  • Solvent extraction5

Effect types

  • Reproductive1

Target tissues

  • Uterus1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AndrographolideLeavesSolvent extractionGelpermeation, High Performance Thin Layer Chromatography (HPTLC)Resolve DOI
AlkaloidsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
Cardiac glycosidesRoots and other underground partsSolvent extractionPhytochemical screeningNo resolvable identifier
SaponinsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
ReproductiveUterusRoots and other underground partsSolvent extractionRat (as animal)Reproduction toxicityNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Florence, A.R., Joselin, J., Jeeva, S. Intra-specific variation of bioactive principles in select members of the genus Clerodendrum L. Journal of chemical and pharmaceutical research, 2012, vol. 4, no. 11, p. 4908-4914.
  2. Kumar, D., Kumar, A., Prakash, O. Post-coital antifertility activity of clerodendrum phlomidis Linn. Dichloromethane root extract. Pharmacologyonline, 2010, vol. 3, p. 479-485.
  3. Bharitkar, Yogesh P., Hazra, Abhijit., Shah, Siddharth., Saha, Sudeshna., Matoori, Anil Kumar., Mondal, Nirup B. New flavonoid glycosides and other chemical constituents from Clerodendrum phlomidis leaves: isolation and characterisation.. Natural product research, 2015, vol. 29, no. 19, p. 1850-6. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue